Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention.

Borreani C, Bianchi E, Pietrolongo E, Rossi I, Cilia S, Giuntoli M, Giordano A, Confalonieri P, Lugaresi A, Patti F, Grasso MG, de Carvalho LL, Palmisano L, Zaratin P, Battaglia MA, Solari A; PeNSAMI project.

PLoS One. 2014 Oct 6;9(10):e109679. doi: 10.1371/journal.pone.0109679. eCollection 2014.

PMID:
25286321
[PubMed - in process]
Free PMC Article
2.

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

Spelman T, Gray O, Trojano M, Petersen T, Izquierdo G, Lugaresi A, Hupperts R, Bergamaschi R, Duquette P, Grammond P, Giuliani G, Boz C, Verheul F, Oreja-Guevara C, Barnett M, Grand'Maison F, Edite Rio M, Lechner-Scott J, Van Pesch V, Fernandez Bolanos R, Flechter S, Den Braber-Moerland L, Iuliano G, Amato MP, Slee M, Cristiano E, Saladino ML, Paine M, Vella N, Kasa K, Deri N, Herbert J, Moore F, Petkovska-Boskova T, Alroughani R, Savino A, Shaw C, Vucic S, Santiago V, Bacile EA, Skromne E, Poehlau D, Cabrera-Gomez JA, Lucas R, Butzkueven H.

Ann Neurol. 2014 Oct 4. doi: 10.1002/ana.24287. [Epub ahead of print]

PMID:
25283272
[PubMed - as supplied by publisher]
3.

The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population.

Goretti B, Niccolai C, Hakiki B, Sturchio A, Falautano M, Eleonora M, Martinelli V, Incerti C, Nocentini U, Murgia M, Fenu G, Cocco E, Marrosu M, Garofalo E, Ambra F, Maddestra M, Consalvo M, Viterbo R, Trojano M, Losignore N, Zimatore G, Pietrolongo E, Lugaresi A, Langdon D, Portaccio E, Amato M.

BMC Neurol. 2014 Sep 10;14(1):171. [Epub ahead of print]

PMID:
25204350
[PubMed - as supplied by publisher]
Free PMC Article
4.

Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.

Lugaresi A, Rottoli MR, Patti F.

Expert Rev Neurother. 2014 Sep;14(9):1029-42. doi: 10.1586/14737175.2014.945523. Epub 2014 Aug 11.

PMID:
25109614
[PubMed - in process]
5.

Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.

Totaro R, Lugaresi A, Bellantonio P, Danni M, Costantino G, Gasperini C, Florio C, Pucci E, Maddestra M, Spitaleri D, Lus G, Ardito B, Farina D, Rossi M, Di Carmine C, Altobelli E, Maccarone B, Casalena A, De Luca G, Travaglini D, Di Ioia M, Di Tommaso V, Fantozzi R, Ruggieri S, Provinciali L, De Riso S, Mundi C, Fuiani A, Galgani S, Ruggieri S, Maniscalco GT, Giuliani G, Cartechini E, Petretta V, Fratta M, Alfieri G, Gatto M, Carolei A; Natalizumab Long-Term Treatment Study group.

Int J Immunopathol Pharmacol. 2014 Apr-Jun;27(2):147-54.

PMID:
25004826
[PubMed - indexed for MEDLINE]
6.

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.

Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Sturchio A, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, Mancardi GL, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

BMC Neurol. 2014 May 26;14:114. doi: 10.1186/1471-2377-14-114.

PMID:
24884599
[PubMed - in process]
Free PMC Article
7.

Risk of relapse phenotype recurrence in multiple sclerosis.

Kalincik T, Buzzard K, Jokubaitis V, Trojano M, Duquette P, Izquierdo G, Girard M, Lugaresi A, Grammond P, Grand'Maison F, Oreja-Guevara C, Boz C, Hupperts R, Petersen T, Giuliani G, Iuliano G, Lechner-Scott J, Barnett M, Bergamaschi R, Van Pesch V, Amato MP, van Munster E, Fernandez-Bolanos R, Verheul F, Fiol M, Cristiano E, Slee M, Rio ME, Spitaleri D, Alroughani R, Gray O, Saladino ML, Flechter S, Herbert J, Cabrera-Gomez JA, Vella N, Paine M, Shaw C, Moore F, Vucic S, Savino A, Singhal B, Petkovska-Boskova T, Parratt J, Sirbu CA, Rozsa C, Liew D, Butzkueven H; MSBase Study Group.

Mult Scler. 2014 Oct;20(11):1511-22. doi: 10.1177/1352458514528762. Epub 2014 Apr 28.

PMID:
24777276
[PubMed - in process]
8.

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.

Laroni A, Brogi D, Morra VB, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL; EAP Investigators.

BMC Neurol. 2014 Apr 1;14:65. doi: 10.1186/1471-2377-14-65.

PMID:
24690227
[PubMed - in process]
Free PMC Article
9.

Fingolimod after natalizumab and the risk of short-term relapse.

Jokubaitis VG, Li V, Kalincik T, Izquierdo G, Hodgkinson S, Alroughani R, Lechner-Scott J, Lugaresi A, Duquette P, Girard M, Barnett M, Grand'Maison F, Trojano M, Slee M, Giuliani G, Shaw C, Boz C, Spitaleri DL, Verheul F, Haartsen J, Liew D, Butzkueven H; MSBase Study Group.

Neurology. 2014 Apr 8;82(14):1204-11. doi: 10.1212/WNL.0000000000000283. Epub 2014 Mar 7.

PMID:
24610329
[PubMed - indexed for MEDLINE]
10.

Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.

Giordano A, Lugaresi A, Confalonieri P, Granella F, Radice D, Trojano M, Martinelli V, Solari A; on behalf of the SIMS-Practice group.

Mult Scler. 2014 Jan 13;20(9):1234-1243. [Epub ahead of print]

PMID:
24421305
[PubMed - as supplied by publisher]
11.

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.

Portaccio E, Ghezzi A, Hakiki B, Sturchio A, Martinelli V, Moiola L, Patti F, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):845-50. doi: 10.1136/jnnp-2013-306054. Epub 2014 Jan 8.

PMID:
24403285
[PubMed - indexed for MEDLINE]
12.

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Gallo A, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, Romano S, Musu L, Paolicelli D, Patti F, Pozzilli C, Rossi S, Salvetti M, Tedeschi G, Tola MR, Troiano M, Zaffaroni M, Malucchi S; Italian Multiple Sclerosis Study group.

Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29.

PMID:
24374787
[PubMed - indexed for MEDLINE]
13.

The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals.

Bassi M, Falautano M, Cilia S, Goretti B, Grobberio M, Pattini M, Pietrolongo E, Viterbo RG, Amato MP, Benin M, Lugaresi A, Martinelli V, Montanari E, Patti F, Trojano M, Delle Fave A.

J Neurol Sci. 2014 Feb 15;337(1-2):67-73. doi: 10.1016/j.jns.2013.11.018. Epub 2013 Nov 19.

PMID:
24289888
[PubMed - indexed for MEDLINE]
14.

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.

Kalincik T, Vivek V, Jokubaitis V, Lechner-Scott J, Trojano M, Izquierdo G, Lugaresi A, Grand'maison F, Hupperts R, Oreja-Guevara C, Bergamaschi R, Iuliano G, Alroughani R, Van Pesch V, Amato MP, Slee M, Verheul F, Fernandez-Bolanos R, Fiol M, Spitaleri DL, Cristiano E, Gray O, Cabrera-Gomez JA, Shaygannejad V, Herbert J, Vucic S, Needham M, Petkovska-Boskova T, Sirbu CA, Duquette P, Girard M, Grammond P, Boz C, Giuliani G, Rio ME, Barnett M, Flechter S, Moore F, Singhal B, Bacile EA, Saladino ML, Shaw C, Skromne E, Poehlau D, Vella N, Spelman T, Liew D, Kilpatrick TJ, Butzkueven H; MSBase Study Group.

Brain. 2013 Dec;136(Pt 12):3609-17. doi: 10.1093/brain/awt281. Epub 2013 Oct 18.

PMID:
24142147
[PubMed - indexed for MEDLINE]
15.

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

Hughes SE, Spelman T, Gray OM, Boz C, Trojano M, Lugaresi A, Izquierdo G, Duquette P, Girard M, Grand'Maison F, Grammond P, Oreja-Guevara C, Hupperts R, Bergamaschi R, Giuliani G, Lechner-Scott J, Barnett M, Edite Rio M, van Pesch V, Amato MP, Iuliano G, Slee M, Verheul F, Cristiano E, Fernández-Bolaños R, Poehlau D, Saladino ML, Deri N, Cabrera-Gomez J, Vella N, Herbert J, Skromne E, Savino A, Shaw C, Moore F, Vucic S, Petkovska-Boskova T, McDonnell G, Hawkins S, Kee F, Butzkueven H; MSBase study group.

Mult Scler. 2014 May;20(6):739-46. doi: 10.1177/1352458513507816. Epub 2013 Oct 9.

PMID:
24107309
[PubMed - in process]
16.

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.

Lugaresi A, di Ioia M, Travaglini D, Pietrolongo E, Pucci E, Onofrj M.

Neuropsychiatr Dis Treat. 2013;9:893-914. doi: 10.2147/NDT.S45144. Epub 2013 Jun 24.

PMID:
23836975
[PubMed]
Free PMC Article
17.

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis.

Kalincik T, Spelman T, Trojano M, Duquette P, Izquierdo G, Grammond P, Lugaresi A, Hupperts R, Cristiano E, Van Pesch V, Grand'maison F, La Spitaleri D, Rio ME, Flechter S, Oreja-Guevara C, Giuliani G, Savino A, Amato MP, Petersen T, Fernandez-Bolanos R, Bergamaschi R, Iuliano G, Boz C, Lechner-Scott J, Deri N, Gray O, Verheul F, Fiol M, Barnett M, van Munster E, Santiago V, Moore F, Slee M, Saladino ML, Alroughani R, Shaw C, Kasa K, Petkovska-Boskova T, den Braber-Moerland L, Chapman J, Skromne E, Herbert J, Poehlau D, Needham M, Bacile EA, Arruda WO, Paine M, Singhal B, Vucic S, Cabrera-Gomez JA, Butzkueven H; MSBase Study Group.

PLoS One. 2013 May 21;8(5):e63480. doi: 10.1371/journal.pone.0063480. Print 2013.

PMID:
23704913
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments.

Pietrolongo E, Giordano A, Kleinefeld M, Confalonieri P, Lugaresi A, Tortorella C, Pugliatti M, Radice D, Goss C, Heesen C, Solari A; AutoMS group.

PLoS One. 2013;8(4):e60721. doi: 10.1371/journal.pone.0060721. Epub 2013 Apr 2.

PMID:
23565270
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.

Ghezzi A, Pozzilli C, Grimaldi LM, Moiola L, Brescia-Morra V, Lugaresi A, Lus G, Rinaldi F, Rocca MA, Trojano M, Bianchi A, Comi G, Filippi M; Italian MS Study Group.

Mult Scler. 2013 Jul;19(8):1106-12. doi: 10.1177/1352458512471878. Epub 2013 Feb 11.

PMID:
23401129
[PubMed - indexed for MEDLINE]
20.

Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study.

D'Alessandro R, Vignatelli L, Lugaresi A, Baldin E, Granella F, Tola MR, Malagù S, Motti L, Neri W, Galeotti M, Santangelo M, Fiorani L, Montanari E, Scandellari C, Benedetti MD, Leone M.

J Neurol. 2013 Jun;260(6):1583-93. doi: 10.1007/s00415-013-6838-x. Epub 2013 Feb 3.

PMID:
23377434
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk